アジア太平洋地域の脊髄損傷治療市場：タイプ別（非手術的管理および手術的管理）、損傷タイプ別（完全脊髄損傷および部分脊髄損傷）、損傷レベル別（頸部脊髄損傷、胸部脊髄損傷、腰部脊髄損傷、および仙骨脊髄損傷）、性別別（男性および女性）、エンドユーザー別（病院、外傷センター、専門クリニック、診療所、外来および研究センター、その他） - 2032年までの業界動向および予測
アジア太平洋地域脊髄損傷治療市場分析
2021年5月にInternational Journal of Health Policy and Managementに掲載された記事によると、脊髄損傷（SCI）の健康研究分野においてパートナーシップアプローチがますます普及しており、SCI研究パートナーシップのリーダーの成功事例を探求し、そこから学ぶ機会が生まれています。アジア太平洋地域の脊髄損傷治療市場における協力関係の拡大とパートナーシップの拡大は、イノベーションの推進、研究の進歩、そして患者ケアの向上に極めて重要です。多様な分野の専門知識を組み合わせることで、これらの協力関係は革新的な治療法の開発を促進し、リハビリテーション技術を向上させ、医療機器の改良につながります。
アジア太平洋地域の脊髄損傷治療市場規模
アジア太平洋地域の脊髄損傷治療市場は、2024年の16億1,000万米ドルから2032年には26億1,000万米ドルに達し、2025年から2032年の予測期間に6.3%のCAGRで成長すると予想されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジ市場調査がまとめた市場レポートには、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。
アジア太平洋地域の脊髄損傷治療市場動向
「成長するコラボレーションと拡大するパートナーシップ」
脊髄損傷（SCI）研究の発展分野において、注目すべき傾向として、学術機関、研究機関、製薬会社、医療機器メーカー間の連携が拡大しています。これらの連携により、再生能力の限界や治療の複雑さといったSCI固有の課題に取り組むための専門知識、リソース、資金の共有が促進されます。多様な強みを結集することで、これらのパートナーシップは幹細胞治療、神経補綴、遺伝子治療といった革新的な治療法の開発を加速させています。さらに、業界の関係者は、リハビリテーションプログラムの強化、移動補助具の改良、診断ツールの改善に向けて協力しています。新たな傾向として、臨床データの共同共有が挙げられます。これはSCIの病態生理学への理解を深め、個々の患者に合わせた治療戦略の策定に役立ちます。さらに、アジア太平洋地域の医療提供者と政策立案者間の連携は、最先端の治療へのアクセスを向上させ、その費用対効果を確保する改革を推進しています。全体として、こうした協力的な傾向は、治療の水準を高めるだけでなく、脊髄損傷を治療するための世界的な取り組みを推進し、最終的には患者たちの生活を変えることになります。
レポートの範囲とアジア太平洋地域の脊髄損傷治療市場のセグメンテーション
|
属性 |
アジア太平洋地域の脊髄損傷治療市場の洞察 |
|
対象セグメント |
|
|
対象地域 |
中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 |
|
主要な市場プレーヤー |
ノバルティスAG（スイス）、ファイザー社（米国）、メドトロニック社（アイルランド）、ジンマー・バイオメット社（米国）、アボット社（米国）、アムニール・ファーマシューティカルズLLC（米国）、サノフィ社（フランス）、アクソニス・セラピューティクス社（米国）、ザイダス・グループ社（インド）、リネージ・セル・セラピューティクス社（米国）、サン・ファーマシューティカル・インダストリーズ社（インド）、キャンバー・ファーマシューティカルズ社（米国）、ドクター・レディーズ・ラボラトリーズ社（インド）、テバ・ファーマシューティカルズUS社（イスラエル）、ニクサン・ファーマシューティカルズ社（インド）、コヴィス・ファーマ社（スイス）、インディアン・スピナル・インジュリーズ・センター社（インド）、ジュビラント・カディスタ・ファーマシューティカルズ社（米国）、ジョンソン・エンド・ジョンソン社（米国）、ナーヴジェン・ファーマ社（カナダ）、アドバケア・ファーマ社（米国）、ボストン・サイエンティフィック社（米国）、ヴァスダ・ファーマ社（インド）、エノマーク社（インド）、グレンマーク・ファーマシューティカルズUS社（米国）、イノバPharmaceuticals（オーストラリア）、Globus Medical（米国）、Zimvie Inc.（米国）、Bioaxone（カナダ） |
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。 |
アジア太平洋地域脊髄損傷治療市場の定義
脊髄治療には、脊髄に影響を与える損傷、疾患、または障害を管理するための様々な医学的アプローチが含まれます。重症度と状態に応じて、症状を軽減するための鎮痛剤、抗炎症剤、筋弛緩剤などの薬物療法が含まれる場合があります。安定化と修復のために、除圧術や脊椎固定術などの外科的介入が必要になる場合もあります。理学療法は可動性の回復と筋力強化に役立ち、リハビリテーション療法は日常生活と自立をサポートします。車椅子や装具などの補助器具は動作を補助し、幹細胞療法などの新しい治療法は再生を促進する可能性があります。心理的サポートや、鍼治療や水治療法などの代替療法も回復を促進します。より良い結果を得るには、多分野にわたるアプローチと早期介入が不可欠です。
アジア太平洋地域の脊髄損傷治療市場の動向
ドライバー
- 協力関係の拡大とパートナーシップの拡大
SCI研究が進展するにつれ、学術機関、研究機関、製薬会社、医療機器メーカー間の連携がますます重要になっています。これらの連携により、専門知識、リソース、資金を結集し、再生能力の限界や治療の複雑さなど、脊髄損傷に伴う重大な課題を克服することが可能になります。こうした連携を通じて、幹細胞治療、神経補綴、遺伝子治療といった革新的な治療法の開発が加速しています。さらに、業界関係者は、より効果的なリハビリテーションプログラムの開発、移動補助具などの医療機器の改良、より優れた診断ツールの確立に向けて協力しています。連携の拡大は、SCIの病態生理学への理解を深め、個別化された治療戦略を最適化するために不可欠な臨床データを共有するためのプラットフォームも提供します。さらに、世界中の医療提供者と政策立案者間の連携は、医療改革の推進、最先端治療へのアクセス向上、そしてSCI治療の経済的負担の軽減に貢献します。最終的には、こうしたパートナーシップの拡大により、ケアの質が向上するだけでなく、脊髄損傷の治療法を見つける世界的な取り組みにも貢献し、イノベーションを推進し、世界中で脊髄損傷に苦しむ人々の生活を向上させます。
例えば、
- 2021年5月、国際保健政策管理ジャーナルに掲載された記事によると、パートナーシップアプローチは脊髄損傷（SCI）の健康研究分野でますます人気が高まっており、SCI研究パートナーシップのチャンピオンの成功を探求し、そこから学ぶ機会が生まれています。
- TechTarget Networkに掲載された記事によると、2023年5月、リーブ財団とアルバータ大学は、脊髄損傷研究におけるオープンデータ共有を促進し、価値、知識の共有、データの透明性を高めることを目指して提携しました。アルバータ大学とリーブ財団は、脊髄損傷のためのオープンデータコモンズ（ODC-SCI）を通じてオープンデータ共有を促進するための3年間の共同プロジェクトを開始しました。
- 世界の脊髄損傷治療市場における連携の拡大とパートナーシップの拡大は、イノベーションの推進、研究の進展、そして患者ケアの向上に極めて重要です。多様な分野の専門知識を組み合わせることで、これらの連携は革新的な治療法の開発を促進し、リハビリテーション技術を向上させ、医療機器の改良につながります。その結果、脊髄損傷の患者は、より効果的で個別化された治療とより良い転帰の恩恵を受けることができます。パートナーシップへの継続的な投資により、市場は脊髄損傷の治療と潜在的な治癒の両面で大きな進歩を遂げ、最終的には世界中の何百万人もの人々の生活の質を向上させることが期待されます。
治療法における技術的進歩
幹細胞療法、神経補綴、高度な神経刺激技術といったイノベーションは、脊髄損傷（SCI）患者の回復の見通しを大きく改善しています。ロボット外骨格や、個別化治療計画のための人工知能（AI）の開発は、リハビリテーションの成果を向上させています。さらに、脊髄再生のための生体材料やCRISPRなどの遺伝子編集技術の飛躍的進歩は、失われた機能の回復に新たな希望をもたらしています。これらの最先端治療は、治療効果を高めるだけでなく、より多くの患者が生活の質を向上させるための高度なソリューションを求めるにつれて、市場を拡大しています。
例えば、
- 2023年10月、NCBIが発表した論文によると、脊髄損傷（SCI）治療における技術進歩、例えばハイドロゲルのような柔軟な生体材料の開発は、組織修復における課題の解決に貢献しています。これらの材料は、損傷部の形状に適応し、線維化を防ぎ、軸索の成長を促進することで、脊髄再生をサポートします。
- 2021年7月、NCBIが発表した論文によると、硬膜外電気刺激（EES）などの脊髄損傷（SCI）治療における技術的進歩は、前臨床研究と臨床研究の両方で有望な結果を示しています。EESは脊髄損傷後の感覚機能と運動機能を向上させ、回復成果を向上させる可能性を示唆しています。この革新は、脊髄損傷（SCI）のリハビリテーションにおける電気刺激の役割の拡大を浮き彫りにしています。
- 技術の進歩は脊髄損傷治療の状況を一変させ、患者に新たな希望をもたらし、回復の成果を大幅に向上させています。幹細胞療法、神経補綴、神経刺激療法、そして人工知能を活用した個別化治療におけるイノベーションは、リハビリテーションの見通しを明るくしています。生体材料と遺伝子編集におけるブレークスルーは、脊髄再生の限界をさらに押し広げ、失われた機能を回復させ、生活の質を向上させています。これらの最先端治療が進化を続けるにつれ、脊髄損傷治療市場は成長し、より高度で効果的なソリューションを必要とする人々に提供していくでしょう。
機会
- 高齢化人口の増加
加齢に伴い、骨密度、筋力、バランス能力が低下することが多く、転倒しやすくなります。これは、この年齢層における脊髄損傷（SCI）の主な原因です。こうした年齢層の変化は、専門的な治療とリハビリテーションサービスを必要とする患者基盤の増加につながっています。負傷後の即時的なケアだけでなく、疼痛、痙縮、褥瘡など、継続的な医療ケアを必要とする脊髄損傷（SCI）関連の合併症の長期的な管理も求められています。
例えば、
- 2024年1月、Population Reference Bureau（人口参考局）が発表した記事によると、65歳以上のアメリカ人の数は2022年の5,800万人から2050年には8,200万人（47%増）に増加すると予測されており、65歳以上の人口が総人口に占める割合は17%から23%に上昇すると予測されています。脊椎損傷を起こしやすい高齢者人口の増加は、需要を押し上げ、脊椎損傷治療市場の拡大につながるでしょう。
- 2019年10月に米国国立医学図書館が発表した論文によると、研究の60%において、機能障害のレベル、機能的困難、日常生活動作、身体能力が特定されていました。このレビューは、高齢者における腰痛の有病率の高さと機能障害を示唆しています。
さらに、高齢者人口は脊髄損傷（SCI）治療において特有の課題を抱えることが多く、個々に合わせたアプローチと革新的なソリューションが求められます。高齢者は既往症を抱えている場合があり、治療計画を複雑にし、専門的なケア戦略が必要となることがあります。こうした状況から、年齢に応じた治療法や補助器具の研究開発が求められています。さらに、SCIの身体的側面への対応にとどまらず、高齢患者のメンタルヘルスサポート、社会統合、そして生活の質の向上にも焦点が当てられています。したがって、高齢者人口の増加は脊髄損傷（SCI）治療市場の成長と多様化を促進する触媒として機能し、関係者は高齢者のニーズに合わせた包括的なケアソリューションを革新的に提供することを迫られています。
- 外傷の発生率の上昇
自動車事故、転倒、スポーツ傷害、暴力などによる外傷は、世界の脊髄損傷（SCI）治療市場にとって大きなビジネスチャンスとなります。これらの事故の発生頻度が高まるにつれ、脊髄損傷を患う人の数も増加し、治療対象となる潜在的な患者基盤が拡大します。この傾向は、特に危険性の高い活動に従事する傾向にある若年層で顕著です。その結果、救急治療、外科的介入、リハビリテーションサービス、支援技術など、効果的かつ高度な治療オプションへの需要が高まり、SCI治療市場の成長を牽引しています。医療機器メーカー、製薬会社、医療機関は、外傷性SCI患者のニーズに合わせた革新的な治療法やサービスを開発・販売することで、このトレンドを活かすことができます。
例えば、
- 2022年6月、米国国立医学図書館が発表した論文によると、脊髄損傷（SCI）の発生率と負担は過去30年間で増加しています。男性と高齢者は、女性や若年層よりも大きな影響を受けています。SCIの主な原因は、転倒と交通事故でした。
- 世界保健機関（WHO）が発表した記事によると、2024年4月時点で、世界で1,500万人以上が脊髄損傷（SCI）を抱えて生活しています。SCIの多くは、転倒、交通事故、暴力などの外傷が原因です。
外傷の発生率の上昇は、世界の脊髄損傷（SCI）治療市場の大幅な拡大を促し、様々な医療分野に機会を生み出しています。この患者集団の特定のニーズに合わせた革新的で効果的なソリューションに注力することが不可欠です。高度な治療法の継続的な開発と提供は、高まる需要に応え、脊髄損傷に苦しむ人々の転帰を改善する上で極めて重要です。
- 人工知能とビッグデータ分析の導入
AIを活用したアルゴリズムと膨大な患者データを活用することで、研究者はこれまで知られていなかったパターンや相関関係を特定し、より効果的な治療戦略や個別化されたケアプランの開発につながります。AIは、治療結果の予測、リハビリテーション計画の最適化、患者ケアプロセスの合理化を支援します。さらに、機械学習アルゴリズムの活用は、高リスク患者の特定、積極的な介入、合併症の発生率の低減に役立ちます。このデータ主導のアプローチは、より正確な診断ツールや予測モデルの開発を促進し、最終的には脊髄損傷（SCI）患者のケアの質の向上につながります。
例えば、
- 2023年4月、国立医学図書館が発表した論文によると、急性脊髄損傷の治療において、生成AIはバイタルサイン、検査結果、その他の患者データを分析することで、褥瘡、尿路感染症、その他の合併症の可能性を予測できるようになる。これにより、臨床医は早期に介入することができ、患者の転帰を改善し、医療費を削減することができる。
- 2023年4月、European Journal of Radiology誌に掲載された論文によると、脊椎における初期のAI応用は、局所病変の評価において顕著な有用性を示している。例えば、一部のアルゴリズムは、通常のMR画像では検出できない脊髄の圧迫性脊髄症の早期変化や脱髄病変を検出できるようになった。
AI主導のインサイトを活用することで、メーカーは個々の患者固有のニーズに応える、より効果的で適応性の高い支援技術を設計・開発できます。さらに、遠隔医療や遠隔モニタリングプラットフォームの活用は患者のエンゲージメントとコンプライアンスの向上につながり、AI搭載のチャットボットやバーチャルアシスタントは患者に24時間365日のサポートとガイダンスを提供できます。脊髄損傷（SCI）治療市場の関係者は、AIとビッグデータ分析を活用することで、患者ケアに革命をもたらし、医療サービスの効率を高め、業界の成長を促進することができます。テクノロジーとヘルスケアの融合は、より効果的な治療法の創出、患者アウトカムの改善、そしてよりパーソナライズされた脊髄損傷（SCI）ケアへのアプローチにつながる可能性があります。
制約/課題
- 脊髄治療の潜在的なリスク、副作用、合併症
脊髄損傷に対する現在の治療法には、外科的介入や薬物療法などがあり、さまざまな副作用、合併症、そして長期的なリスクを伴います。外科的処置は特定の損傷に対しては不可欠ですが、感染症、出血、あるいは周辺組織の損傷を引き起こす可能性があり、患者の状態をさらに悪化させる可能性があります。さらに、手術の結果として、麻痺や運動機能の喪失といった神経学的合併症が発生する可能性も常に存在します。薬物療法の場合、吐き気、めまい、鎮痛剤への依存といった副作用が回復過程を複雑にする可能性があります。より重篤な症例では、疼痛や炎症を抑えるために使用される薬物療法が、臓器障害や免疫抑制といった長期的な問題につながる可能性があります。これらのリスクは、特に健康状態の悪化や新たな合併症の発症を懸念する多くの患者が、これらの治療法の追求を躊躇させる要因となっています。その結果、一部の患者はこれらの治療を避けたり、遅らせたりして、十分な臨床試験が行われていない可能性のある代替療法や非従来的なアプローチを選択することがあります。こうした従来の治療法への抵抗は、最終的に患者の回復過程に影響を与え、改善の遅れや全体的な治療効果の低下につながる可能性があります。さらに、脊髄損傷（SCI）の生涯にわたる後遺症に苦しむ患者にとって、継続的な治療リスクや合併症の負担は、身体的および精神的な負担をさらに増大させ、治療を継続するという決断をさらに困難にする可能性があります。
例えば
- 2024年12月、NCBIが発表した論文によると、慢性または腫瘍性の脊髄損傷（SCI）は、持続的な腰痛、全身症状（体重減少、発熱、食欲不振）、進行性の感覚運動機能低下などの症状を呈することがあります。病変が拡大するにつれて、握力や運動機能の低下などの運動障害が現れることがあります。リスク要因としては、喫煙、過去の癌治療、結核への曝露、最近の手術、免疫抑制などが挙げられます。
- 2025年1月、NCBIが発表した論文によると、脊髄損傷（SCI）は、肺炎、循環器系の問題、筋硬直、自律神経失調症、褥瘡、神経性疼痛、膀胱・腸管障害、性機能障害、うつ病など、様々な合併症を引き起こす可能性があります。これらの問題に対処するには、患者は綿密なモニタリング、予防措置、そして薬物療法、理学療法、精神的サポートといった専門的な治療を必要とします。
外科的治療と薬物療法は脊髄損傷の回復に不可欠ですが、感染症、神経学的合併症、長期的な副作用など、大きなリスクを伴います。これらの潜在的な欠点は、患者がさらなる悪影響や生活の質の低下を恐れ、これらの治療の追求や完全な治療へのコミットメントを躊躇させる原因となることがよくあります。その結果、患者は代替療法に頼ることになりますが、必ずしも効果的とは限りません。これは、より安全で効果的な治療法の必要性を強調するものであり、脊髄損傷患者をより良くサポートするためには、潜在的なリスクと回復の可能性のバランスをとった包括的なケアを提供することの重要性を浮き彫りにしています。
- 脊髄損傷の治療に関する理解の不足
脊髄損傷（SCI）の複雑な病態生理に関する理解が不十分なため、効果的な治療法の開発が著しく阻害され、世界のSCI治療市場にとって大きな課題となっています。SCIは分子レベルおよび細胞レベルで一連の事象を引き起こし、神経損傷、炎症、グリア瘢痕形成といった機能障害を引き起こします。これらの複雑なプロセスを完全に理解していないため、正確な治療標的を特定し、神経再生と機能回復を効果的に促進する介入を設計することが困難です。その結果、現在の多くの治療法は、SCIの根本原因への対処よりも、症状の管理と合併症の予防に重点を置いています。
例えば、
- 2020年10月、国立医学図書館に掲載された論文によると、脊髄損傷後の複雑な特徴、多くの矛盾、複雑な病態生理学的結果などの異質な要因が、脊髄損傷治療の理解不足と失敗の主な原因となっている。
- 2023年2月、オックスフォード大学出版局が発表した論文によると、脊髄損傷（SCI）の病態生理は複雑かつ多面的であるため、特定の側面やプロセスに作用する個別の治療法では、脊髄損傷後の神経再生や機能回復を促すには不十分である。
この知識ギャップは、個別化治療戦略の開発を阻害しています。SCIは均一な病態ではなく、個々の患者は損傷の重症度、神経障害、機能障害の程度が異なります。各患者の損傷を引き起こす具体的なメカニズムを徹底的に理解しなければ、個々のニーズに合わせた治療計画を策定することが困難になります。これは、最適な治療結果が得られず、患者満足度の低下につながる可能性があります。さらに、SCIに関する理解の不足は、正確な診断ツールやバイオマーカーの開発を妨げ、治療効果のモニタリングや長期的な転帰の予測を困難にしています。この課題を克服するには、SCIの複雑さを解明し、より効果的で標的を絞った治療法への道を開くため、基礎研究とトランスレーショナル研究への多大な投資が必要です。
アジア太平洋地域の脊髄損傷治療市場の展望
市場は、種類、傷害の種類、傷害の程度、性別、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメント間の成長は、業界における成長の少ないセグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的意思決定を支援します。
タイプ
- 非手術的管理
- 治療
- リハビリテーション療法
- 物理的な
- 作業療法または言語療法
- 脊髄内バクロフェン療法（IBT）
- リハビリテーション療法
- 薬
- 抗けいれん薬
- コルチコステロイド
- メチルプレドニゾロン
- デキサメタゾン
- 抗うつ薬
- SSRI（選択的セロトニン再取り込み阻害薬）
- SNRIS（セロトニンおよびノルエピネフリン再取り込み阻害剤）
- 三環系薬剤
- 不安障害の薬
- 鎮痙薬と筋弛緩薬
- ベンゾジアゼピン
- アルファ2作動薬
- その他のGABA作動薬
- その他
- NSAIDs
- イブプロフェン
- ナプロキセン
- その他
- 麻薬性鎮痛剤
- 抗生物質
- β-ラクタム（ペニシリン、セファロスポリン）
- マクロライド系薬剤（アジスロマイシン、エリスロマイシン）
- ミノサイクリン（テトラサイクリン系）
- ダプソン
- その他（フルオロキノロン、アミノグリコシドなど）
- 治療
- 薬剤の種類別
- ジェネリック
- ブランド
- メドロール
- リオレサル
- リリカ
- ニューロンチン
- ザナフレックス
- グラリス
- ホリザント
- リルテック
- 投与経路別
- オーラル
- タブレット
- カプセル
- 非経口
- 経皮パッチ
- 運用管理
- 減圧手術
- 椎間板切除術または微小椎間板切除術
- 椎弓切除術
- 後方微小椎間板切除術/微小減圧術
- 孔切除術
- 脊椎再建手術
- 後頸椎椎弓切除術
- 椎弓切開術
- 椎間板置換術
- 人工頸椎椎間板移植
- 人工椎間板手術／脊椎関節形成術
- 椎間板および関節面の除去
- 頸椎前方椎間板切除術
- 脊椎固定術
- 腰椎固定術
- 頸椎固定術
- 六分儀融合
- 内側椎間関節切除術
- 2つのファセットジョイントを除去
- 1つの関節面を除去
- その他
- 減圧手術
傷害の種類
- 完全脊髄損傷
- 部分的脊髄損傷
負傷レベル
- 頸髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
- 胸部脊髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
- 腰椎脊髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
- 仙骨脊髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
性別
- 男
- アダルト
- 老年
- 子供たち
- 女性
- アダルト
- 老年
- 子供たち
エンドユーザー
- 病院
- 外傷センター
- 専門クリニック
- クリニック
- 外来・研究センター
- その他
流通チャネル
- 病院薬局
- 小売薬局
- オンライン薬局
アジア太平洋地域の脊髄損傷治療市場の地域分析
市場は分析され、市場規模の洞察と傾向は、上記のように国、タイプ、傷害の種類、傷害のレベル、性別、エンドユーザー、流通チャネル別に提供されます。
脊髄損傷治療市場が対象としている国は、中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、およびその他のアジア太平洋諸国です。
中国は、先進的な医療インフラと研究開発への多額の投資により、市場をリードすると予想されています。また、有利な規制政策と強力な産学連携も、イノベーションと市場成長の推進に重要な役割を果たしています。
日本は、医療インフラへの多額の投資と先進技術の台頭により、世界の脊髄損傷治療市場において最も急速に成長している地域です。加えて、政府による支援の拡充、都市化と産業発展による脊髄損傷の発生率の増加も、市場の需要をさらに押し上げています。
本レポートの国別セクションでは、市場の現在および将来の動向に影響を与える、各国の市場に影響を与える要因や国内市場における規制の変更についても解説しています。川下・川上バリューチェーン分析、技術トレンド、ポーターのファイブフォース分析、ケーススタディといったデータポイントは、各国の市場シナリオを予測するための指標として活用されています。また、アジア太平洋地域のブランドの存在と入手可能性、そして現地および国内ブランドとの競争の激しさや希少性によって直面する課題、国内関税や貿易ルートの影響についても、国別データの予測分析において考慮されています。
アジア太平洋地域の脊髄損傷治療市場シェア
市場競争環境は、競合他社ごとに詳細な情報を提供します。企業概要、財務状況、収益、市場ポテンシャル、研究開発投資、新規市場への取り組み、アジア太平洋地域におけるプレゼンス、生産拠点・設備、生産能力、強みと弱み、製品投入、製品群の幅広さ、アプリケーションにおける優位性などの詳細が含まれます。上記のデータは、各社の市場への注力分野にのみ関連しています。
アジア太平洋地域の脊髄損傷治療市場 リーダーは以下のとおりです。
- ノバルティスAG（スイス）
- ファイザー社（米国）
- メドトロニック（アイルランド）
- ジマー・バイオメット（米国）
- アボット（米国）
- アムニール・ファーマシューティカルズLLC（米国）
- サノフィ（フランス）
- アクソニス・セラピューティクス（米国）
- ザイダスグループ（インド）
- リネージセルセラピューティクス社（米国）
- サン・ファーマシューティカル・インダストリーズ（インド）
- キャンバー・ファーマシューティカルズ社（米国）
- ドクター・レディーズ・ラボラトリーズ社（インド）
- テバ・ファーマシューティカルズUS社（イスラエル）
- ニクサン・ファーマシューティカルズ（インド）
- Covis Pharma GmbH（スイス）
- インド脊髄損傷センター（インド）
- ジュビラント・カディスタ・ファーマシューティカルズ社（米国）
- ジョンソン・エンド・ジョンソン（米国）
- ナーヴジェン・ファーマ・コーポレーション（カナダ）
- アドバケア・ファーマ（米国）
- ボストン・サイエンティフィック（米国）
- ヴァスダ・ファーマ（インド）
- エノマーク（インド）
- グレンマーク・ファーマシューティカルズUS社（米国）
- イノバ・ファーマシューティカルズ（オーストラリア）
- グローバス・メディカル（米国）
- Zimvie Inc.（米国）
- バイオアキソン（カナダ）
アジア太平洋地域の脊髄損傷治療市場の最新動向
- 2023年5月、アボットは、FDAが、非外科的腰痛として知られる、腰部手術を受けていない、または受ける資格のない人の慢性腰痛の治療薬として、脊髄刺激（SCS）デバイスを承認したと発表しました。
- 2025年1月、アボットは、同社独自の脊髄刺激（SCS）技術であるBurstDRが、慢性疼痛、特に腰痛や脚の痛みに悩む人々に長期的かつ持続的な緩和効果をもたらすことを示す新たな4年間のデータを発表しました。このデータは、患者が治療に高い満足度を示していることを裏付けるものであり、複数年にわたる追跡調査の4年目の成果を表しており、フロリダ州オーランドで開催される北米神経調節（NANS）2025年次総会で発表されます。
- 2024年8月、ジンマー・バイオメットはOrthoGrid Systemsの買収契約を締結し、OrthoGridのAI駆動型Hip AI手術ガイダンスプラットフォームを導入することで股関節ポートフォリオを拡大しました。この買収には、AIを活用した透視ベースのシステムが含まれており、手術の精度と効率性を向上させます。
- 2020年12月、キャンバー・ファーマシューティカルズはリオレサールのジェネリック医薬品であるバクロフェン錠を発売しました。バクロフェンは、多発性硬化症や脊髄損傷などの症状における筋肉痛、けいれん、こわばりの治療に用いられます。10mgと20mgの2種類の用量があり、筋肉を弛緩させ、不快感を和らげることで、これらの症状の緩和をもたらします。
- 2020年12月、Globus Medicalは、米国の大手グループ購買組織であるPremierとのグループ購買契約を締結したことを発表しました。この契約により、市場での信頼性が高まり、将来の収益増加につながります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: REGULATIONS
5.1 ONGOING COMPLIANCE AND UPDATES:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING COLLABORATION AND EXPANDING PARTNERSHIPS
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN TREATMENT METHODS
6.1.3 INCREASING HEALTHCARE EXPENDITURE
6.1.4 ENHANCED REHABILITATION TECHNIQUES
6.2 RESTRAINTS
6.2.1 POTENTIAL RISKS, SIDE EFFECTS, AND COMPLICATIONS OF SPINAL CORD TREATMENTS
6.2.2 REGULATORY BARRIERS LIMIT MARKET GROWTH BY DELAYING TREATMENT APPROVALS AND ACCESSIBILITY
6.3 OPPORTUNITIES
6.3.1 RISING GERIATRIC POPULATION
6.3.2 RISING INCIDENCE OF TRAUMATIC INJURIES
6.3.3 INCORPORATION OF ARTIFICIAL INTELLIGENCE AND BIG DATA ANALYTICS
6.4 CHALLENGES
6.4.1 LIMITED UNDERSTANDING RELATED TO SPINAL CORD INJURY TREATMENTS
6.4.2 HIGH COSTS ASSOCIATED WITH THE TREATMENTS
7 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE
7.1 OVERVIEW
7.2 NON-OPERATIVE MANAGEMENT
7.2.1 THERAPY
7.2.1.1 Rehabilitation Therapy
7.2.1.1.1 PHYSICAL
7.2.1.1.2 OCCUPATIONAL OR SPEECH THERAPY
7.2.1.2 INTRATHECAL BACLOFEN THERAPY (IBT)
7.2.2 MEDICATION
7.2.2.1 ANTICONVULSANTS
7.2.2.1.1 Pregabalin
7.2.2.1.2 Gabapentin
7.2.2.1.3 Others
7.2.2.2 CORTICOSTEROIDS
7.2.2.2.1 Methylprednisolone
7.2.2.2.2 Dexamethasone
7.2.2.3 ANTIDEPRESSANTS
7.2.2.3.1 SSRIs (Selective Serotonin Reuptake Inhibitors)
7.2.2.3.2 SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors)
7.2.2.3.3 Tricyclic Drugs
7.2.2.3.4 Anxiety Medications
7.2.2.4 ANTISPASMODICS AND MUSCLE RELAXANTS
7.2.2.4.1 Benzodiazepines
7.2.2.4.2 Alpha-2 Agonists
7.2.2.4.3 Other GABA Agonists
7.2.2.4.4 Others
7.2.2.5 NSAIDS
7.2.2.5.1 Ibuprofen
7.2.2.5.2 Naproxen
7.2.2.5.3 Others
7.2.2.6 NARCOTIC ANALGESICS
7.2.2.7 ANTIBIOTICS
7.2.2.7.1 β-Lactams (Penicillins, Cephalosporins)
7.2.2.7.2 Macrolides (Azithromycin, Erythromycin)
7.2.2.7.3 Minocycline (Tetracycline Type)
7.2.2.7.4 Dapsone
7.2.2.7.5 Others (Fluoroquinolones, Aminoglycosides, etc.)
7.2.2.8 Medrol
7.2.2.9 Lioresal
7.2.2.10 Lyrica
7.2.2.11 Neurontin
7.2.2.12 Zanaflex
7.2.2.13 Gralise
7.2.2.14 Rilutek
7.3 OPERATIVE MANAGEMENT
7.3.1 DECOMPRESSION SURGERY
7.3.1.1 Discectomy Or Microdiscectomy
7.3.1.2 Laminectomy
7.3.1.3 Posterior Microdiscectomy/ Microdecompression
7.3.1.4 Foraminectomy
7.3.1.5 Reconstructive Spinal Surgery
7.3.1.6 Posterior Cervical Laminectomy
7.3.1.7 Laminotomy
7.3.2 DISC REPLACEMENT
7.3.2.1 Artificial Cervical Disc Implantation
7.3.2.2 Artificial Disc Surgery/ Spinal Arthroplasty
7.3.3 DISC AND FACET JOINT REMOVAL
7.3.3.1 Anterior Cervical Discectomy
7.3.3.2 Spinal Fusion
7.3.3.2.1 Lumbar Spinal Fusion
7.3.3.2.2 Cervical Spinal Fusion
7.3.3.2.3 Sextant Fusion
7.3.3.3 Medial Facetectomy
7.3.3.3.1 REMOVE TWO FACET JOINT
7.3.3.3.2 REMOVE ONE FACET JOINT
8 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY
8.1 OVERVIEW
8.2 CERVICAL SPINAL CORD INJURIES
8.2.1 COMPLETE SPINAL CORD INJURIES
8.2.2 PARTIAL SPINAL CORD INJURIES
8.3 THORACIC SPINAL CORD INJURIES
8.3.1 COMPLETE SPINAL CORD INJURIES
8.3.2 PARTIAL SPINAL CORD INJURIES
8.4 LUMBAR SPINAL CORD INJURIES
8.4.1 COMPLETE SPINAL CORD INJURIES
8.4.2 PARTIAL SPINAL CORD INJURIES
8.5 SACRAL SPINAL CORD INJURIES
8.5.1 COMPLETE SPINAL CORD INJURIES
8.5.2 PARTIAL SPINAL CORD INJURIES
9 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE
9.1 OVERVIEW
9.2 COMPLETE SPINAL CORD INJURIES
9.3 PARTIAL SPINAL CORD INJURIES
10 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY GENDER
10.1 OVERVIEW
10.2 MALE
10.2.1 ADULT
10.2.2 GERIATIC
10.2.3 CHILDREN
10.3 FEMALE
10.3.1 ADULT
10.3.2 GERIATIC
10.3.3 CHILDREN
11 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 TRAUMA CENTERS
11.4 SPECIALTY CLINICS
11.5 CLINICS
11.6 AMBULATORY AND RESEARCH CENTERS
11.7 OTHERS
12 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 SINGAPORE
12.1.7 THAILAND
12.1.8 MALAYSIA
12.1.9 INDONESIA
12.1.10 TAIWAN
12.1.11 NEW ZEALAND
12.1.12 PHILIPPINES
12.1.13 VIETNAM
12.1.14 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 PFIZER INC.
15.1.1 COMPANY SHARE ANALYSIS
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 MEDTRONIC
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 NOVARTIS AG
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ZIMMER BIOMET
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 AMNEAL PHARMACEUTICALS LLC
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 AXONIS THERAPEUTICS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ADVACARE PHARMA
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIOAXONE BIOSCIENCES
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BOSTON SCIENTIFIC CORPORATION
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 COVIS PHARMA GMBH.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 CAMBER PHARMACEUTICALS, INC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 DR. REDDY’S LABORATORIES LTD
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
15.14 ENOMARK PHARMA
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GLENMARK PHARMACEUTICALS INC.,
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 GLOBUS MEDICAL
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS/NEWS
15.17 INOVA PHARMACEUTICALS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 INDIAN SPINAL INJURIES CENTRE
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 JUBILANT CADISTA PHARMACEUTICALS INC.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON SERVICES, INC
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 LINEAGE CELL THERAPEUTICS, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 ANNUAL REVENUE
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENT
15.22 NERVGEN PHARMA CORP.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PIPELINE PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 NIKSAN PHARMACEUTICAL
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 SUN PHARMACEUTICAL INDUSTRIES LTD.
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENT
15.25 SANOFI
15.25.1 COMPANY SNAPSHOT
15.25.2 REVENUE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENT
15.26 TEVA PHARMACEUTICALS USA, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 REVENUE ANALYSIS
15.26.3 PRODUCT PORTFOLIO
15.26.4 RECENT DEVELOPMENT
15.27 VASUDHA PHARMA
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENT
15.28 ZIMVIE INC.
15.28.1 COMPANY SNAPSHOT
15.28.2 REVENUE ANALYSIS
15.28.3 PRODUCT PORTFOLIO
15.28.4 RECENT NEWS
15.29 ZYDUS GROUP
15.29.1 COMPANY SNAPSHOT
15.29.2 REVENUE ANALYSIS
15.29.3 PRODUCT PORTFOLIO
15.29.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 9 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 10 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 12 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 13 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 15 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 16 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE 2018-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 18 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 19 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 21 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 22 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 24 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 25 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC SPINAL FUSION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE 2018-2032 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC COMPLETE SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC PARTIAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC SPINAL CORD INJURY TREA TMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC HOSPITALS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC TRAUMA CENTERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC SPECIALITY CLINICS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC CLINICS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC AMBULATORY AND RESEARCH CENTERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC OTHERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 68 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 69 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 71 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 72 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 74 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 75 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 77 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 78 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 80 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 81 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 83 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 84 ASIA-PACIFIC OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 ASIA-PACIFIC DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 ASIA-PACIFIC DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 ASIA-PACIFIC DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 ASIA-PACIFIC SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 ASIA-PACIFIC MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 92 ASIA-PACIFIC CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 ASIA-PACIFIC THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 ASIA-PACIFIC LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 ASIA-PACIFIC SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 ASIA-PACIFIC BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 99 ASIA-PACIFIC ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 101 ASIA-PACIFIC MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 102 ASIA-PACIFIC FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 103 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 104 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 105 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 CHINA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 CHINA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 CHINA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 CHINA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 CHINA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 112 CHINA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 113 CHINA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 114 CHINA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 115 CHINA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 116 CHINA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 CHINA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 118 CHINA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 119 CHINA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 CHINA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 121 CHINA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 122 CHINA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 123 CHINA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 124 CHINA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 125 CHINA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 CHINA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 127 CHINA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 128 CHINA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 CHINA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 CHINA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 CHINA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 CHINA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 CHINA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 136 CHINA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 CHINA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 CHINA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 CHINA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 CHINA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 143 CHINA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 145 CHINA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 146 CHINA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 147 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 148 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 149 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 JAPAN NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 151 JAPAN THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 JAPAN REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 JAPAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 JAPAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 156 JAPAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 157 JAPAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 158 JAPAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 159 JAPAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 160 JAPAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 JAPAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 162 JAPAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 163 JAPAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 JAPAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 165 JAPAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 166 JAPAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 JAPAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 168 JAPAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 169 JAPAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 JAPAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 171 JAPAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 172 JAPAN OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 JAPAN DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 JAPAN DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 175 JAPAN DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 JAPAN SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 JAPAN MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 180 JAPAN CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 JAPAN THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 JAPAN LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 JAPAN SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 185 JAPAN BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 187 JAPAN ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 189 JAPAN MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 190 JAPAN FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 191 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 192 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 193 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 INDIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 INDIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 INDIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 INDIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 INDIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 200 INDIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 201 INDIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 INDIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 203 INDIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 204 INDIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 INDIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 206 INDIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 207 INDIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 INDIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 209 INDIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 210 INDIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 INDIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 212 INDIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 213 INDIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 INDIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 215 INDIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 216 INDIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 INDIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 INDIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 INDIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 INDIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 INDIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 222 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 224 INDIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 INDIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 INDIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 INDIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 INDIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 231 INDIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 233 INDIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 234 INDIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 235 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 236 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 237 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 238 SOUTH KOREA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 SOUTH KOREA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 SOUTH KOREA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 SOUTH KOREA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 SOUTH KOREA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 244 SOUTH KOREA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 245 SOUTH KOREA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 SOUTH KOREA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 247 SOUTH KOREA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 248 SOUTH KOREA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 SOUTH KOREA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 250 SOUTH KOREA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 251 SOUTH KOREA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 SOUTH KOREA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 253 SOUTH KOREA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 254 SOUTH KOREA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 SOUTH KOREA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 256 SOUTH KOREA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 257 SOUTH KOREA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 SOUTH KOREA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 259 SOUTH KOREA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 260 SOUTH KOREA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 SOUTH KOREA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 SOUTH KOREA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 SOUTH KOREA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 264 SOUTH KOREA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 SOUTH KOREA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 267 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 268 SOUTH KOREA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 SOUTH KOREA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 SOUTH KOREA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 SOUTH KOREA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 SOUTH KOREA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 274 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 275 SOUTH KOREA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 277 SOUTH KOREA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 278 SOUTH KOREA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 279 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 280 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 281 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 AUSTRALIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 AUSTRALIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 AUSTRALIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 AUSTRALIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 AUSTRALIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 288 AUSTRALIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 289 AUSTRALIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 AUSTRALIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 291 AUSTRALIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 292 AUSTRALIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 AUSTRALIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 294 AUSTRALIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 295 AUSTRALIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 AUSTRALIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 297 AUSTRALIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 298 AUSTRALIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 AUSTRALIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 300 AUSTRALIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 301 AUSTRALIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 AUSTRALIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 303 AUSTRALIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 304 AUSTRALIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 305 AUSTRALIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 AUSTRALIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 307 AUSTRALIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 AUSTRALIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 AUSTRALIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 312 AUSTRALIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 313 AUSTRALIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 AUSTRALIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 AUSTRALIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 316 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 317 AUSTRALIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 319 AUSTRALIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 321 AUSTRALIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 322 AUSTRALIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 323 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 324 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 325 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 326 SINGAPORE NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 SINGAPORE THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 SINGAPORE REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 330 SINGAPORE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 331 SINGAPORE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 332 SINGAPORE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 333 SINGAPORE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 SINGAPORE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 335 SINGAPORE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 336 SINGAPORE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 SINGAPORE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 338 SINGAPORE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 339 SINGAPORE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 340 SINGAPORE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 341 SINGAPORE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 342 SINGAPORE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 SINGAPORE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 344 SINGAPORE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 345 SINGAPORE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 SINGAPORE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 347 SINGAPORE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 348 SINGAPORE OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 SINGAPORE DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 SINGAPORE DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 351 SINGAPORE DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 SINGAPORE SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 SINGAPORE MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 354 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 356 SINGAPORE CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 SINGAPORE THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 SINGAPORE LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 359 SINGAPORE SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 361 SINGAPORE BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 363 SINGAPORE ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 365 SINGAPORE MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 366 SINGAPORE FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 367 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 368 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 369 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 THAILAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 THAILAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 THAILAND REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 373 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 THAILAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 375 THAILAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 376 THAILAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 377 THAILAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 378 THAILAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 379 THAILAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 380 THAILAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 381 THAILAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 382 THAILAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 383 THAILAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 THAILAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 385 THAILAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 386 THAILAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 THAILAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 388 THAILAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 389 THAILAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 THAILAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 391 THAILAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 392 THAILAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 THAILAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 THAILAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 THAILAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 THAILAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 THAILAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 400 THAILAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 THAILAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 THAILAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 403 THAILAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 404 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 THAILAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 406 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 407 THAILAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 409 THAILAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 410 THAILAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 411 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 412 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 413 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 414 MALAYSIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 MALAYSIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 MALAYSIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 417 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 MALAYSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 419 MALAYSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 420 MALAYSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 421 MALAYSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 MALAYSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 423 MALAYSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 424 MALAYSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 425 MALAYSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 426 MALAYSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 427 MALAYSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 MALAYSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 429 MALAYSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 430 MALAYSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 431 MALAYSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 432 MALAYSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 433 MALAYSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 434 MALAYSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 435 MALAYSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 436 MALAYSIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 MALAYSIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 438 MALAYSIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 MALAYSIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 MALAYSIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 MALAYSIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 442 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 444 MALAYSIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 MALAYSIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 446 MALAYSIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 MALAYSIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 MALAYSIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 450 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 451 MALAYSIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 452 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 453 MALAYSIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 454 MALAYSIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 455 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 456 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 457 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 458 INDONESIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 INDONESIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 460 INDONESIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 461 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 462 INDONESIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 463 INDONESIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 464 INDONESIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 465 INDONESIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 INDONESIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 467 INDONESIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 468 INDONESIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 469 INDONESIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 470 INDONESIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 471 INDONESIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 472 INDONESIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 473 INDONESIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 474 INDONESIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 475 INDONESIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 476 INDONESIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 477 INDONESIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 478 INDONESIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 479 INDONESIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 480 INDONESIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 481 INDONESIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 482 INDONESIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 483 INDONESIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 INDONESIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 485 INDONESIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 486 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 487 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 488 INDONESIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 489 INDONESIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 490 INDONESIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 491 INDONESIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 492 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 493 INDONESIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 494 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 495 INDONESIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 496 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 497 INDONESIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 498 INDONESIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 499 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 500 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 501 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 502 TAIWAN NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 503 TAIWAN THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 504 TAIWAN REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 505 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 506 TAIWAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 507 TAIWAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 508 TAIWAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 509 TAIWAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 510 TAIWAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 511 TAIWAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 512 TAIWAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 513 TAIWAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 514 TAIWAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 515 TAIWAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 516 TAIWAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 517 TAIWAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 518 TAIWAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 519 TAIWAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 520 TAIWAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 521 TAIWAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 522 TAIWAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 523 TAIWAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 524 TAIWAN OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 525 TAIWAN DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 526 TAIWAN DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 527 TAIWAN DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 528 TAIWAN SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 529 TAIWAN MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 530 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 531 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 532 TAIWAN CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 533 TAIWAN THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 534 TAIWAN LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 535 TAIWAN SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 536 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 537 TAIWAN BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 538 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 539 TAIWAN ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 540 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 541 TAIWAN MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 542 TAIWAN FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 543 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 544 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 545 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 546 NEW ZEALAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 547 NEW ZEALAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 548 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 549 NEW ZEALAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 550 NEW ZEALAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 551 NEW ZEALAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 552 NEW ZEALAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 553 NEW ZEALAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 554 NEW ZEALAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 555 NEW ZEALAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 556 NEW ZEALAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 557 NEW ZEALAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 558 NEW ZEALAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 559 NEW ZEALAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 560 NEW ZEALAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 561 NEW ZEALAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 562 NEW ZEALAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 563 NEW ZEALAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 564 NEW ZEALAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 565 NEW ZEALAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 566 NEW ZEALAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 567 NEW ZEALAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 568 NEW ZEALAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 569 NEW ZEALAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 570 NEW ZEALAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 571 NEW ZEALAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 572 NEW ZEALAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 573 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 574 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 575 NEW ZEALAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 576 NEW ZEALAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 577 NEW ZEALAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 578 NEW ZEALAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 579 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 580 NEW ZEALAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 581 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 582 NEW ZEALAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 583 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 584 NEW ZEALAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 585 NEW ZEALAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 586 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 587 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 588 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 589 PHILIPPINES NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 590 PHILIPPINES THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 591 PHILIPPINES REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 592 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 593 PHILIPPINES ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 594 PHILIPPINES ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 595 PHILIPPINES ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 596 PHILIPPINES CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 597 PHILIPPINES CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 598 PHILIPPINES CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 599 PHILIPPINES ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 600 PHILIPPINES ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 601 PHILIPPINES ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 602 PHILIPPINES ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 603 PHILIPPINES ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 604 PHILIPPINES ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 605 PHILIPPINES NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 606 PHILIPPINES NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 607 PHILIPPINES NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 608 PHILIPPINES ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 609 PHILIPPINES ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 610 PHILIPPINES ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 611 PHILIPPINES OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 612 PHILIPPINES DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 613 PHILIPPINES DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 614 PHILIPPINES DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 615 PHILIPPINES SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 616 PHILIPPINES MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 617 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 618 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 619 PHILIPPINES CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 620 PHILIPPINES THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 621 PHILIPPINES LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 622 PHILIPPINES SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 623 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 624 PHILIPPINES BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 625 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 626 PHILIPPINES ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 627 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 628 PHILIPPINES MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 629 PHILIPPINES FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 630 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 631 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 632 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 633 VIETNAM NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 634 VIETNAM THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 635 VIETNAM REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 636 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 637 VIETNAM ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 638 VIETNAM ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 639 VIETNAM ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 640 VIETNAM CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 641 VIETNAM CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 642 VIETNAM CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 643 VIETNAM ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 644 VIETNAM ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 645 VIETNAM ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 646 VIETNAM ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 647 VIETNAM ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 648 VIETNAM ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 649 VIETNAM NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 650 VIETNAM NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 651 VIETNAM NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 652 VIETNAM ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 653 VIETNAM ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 654 VIETNAM ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 655 VIETNAM OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 656 VIETNAM DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 657 VIETNAM DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 658 VIETNAM DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 659 VIETNAM SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 660 VIETNAM MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 661 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 662 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 663 VIETNAM CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 664 VIETNAM THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 665 VIETNAM LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 666 VIETNAM SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 667 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 668 VIETNAM BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 669 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 670 VIETNAM ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 671 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 672 VIETNAM MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 673 VIETNAM FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 674 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 675 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 676 REST OF ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
図表一覧
FIGURE 1 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 11 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE
FIGURE 14 GROWING COLLABORATION AND EXPANDING PARTNERSHIPS IS EXPECTED TO DRIVE THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 NON-OPERATIVE MANAGEMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 MARKET OVERVIEW
FIGURE 17 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, 2024
FIGURE 18 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 20 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, 2024
FIGURE 22 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, 2025-2032 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, CAGR (2025-2032)
FIGURE 24 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, 2024
FIGURE 26 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, CAGR (2025-2032)
FIGURE 28 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, 2024
FIGURE 30 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, 2025-2032 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, CAGR (2025-2032)
FIGURE 32 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, 2024
FIGURE 34 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, CAGR (2025-2032)
FIGURE 36 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: SNAPSHOT (2024)
FIGURE 38 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
